Brijesh Yadav

Dr. Brijesh Yadav

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2015 in Cytokine
Verified
Journal Article
Closed access
Narayan PrasadNarayan Prasad
Narayan Prasad
AJAkhilesh K Jaiswal
Akhilesh K Jaiswal
VAVikas Agarwal
Vikas Agarwal
BYBRIJESH YADAV
BRIJESH YADAV
RSRaj Kumar Sharma
Raj Kumar Sharma
ASAjay Singh
Ajay Singh

22 January 2014 in Nephrology
Verified
Journal Article
Closed access
PDF file
Narayan PrasadNarayan Prasad
Narayan Prasad
DGDesraj Gurjer
Desraj Gurjer
DBDharmender Bhadauria
Dharmender Bhadauria
AGAmit Gupta
Amit Gupta
ASAneesh Srivastava
Aneesh Srivastava
RSRaj K Sharma
Raj K Sharma

1 January 2014 in Indian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
NPN Prasad
N Prasad
AJA Jaiswal
A Jaiswal
VAV Agarwal
V Agarwal
BYBRIJESH YADAV
BRIJESH YADAV
DTD Tripathy
D Tripathy
DMD. R. Modi
D. R. Modi
Idiopathic minimal change disease is a disorder of T-cell dysfunction. The relative predominance of regulatory T cells (Tregs), Th1, and Th2 cells in nephrotic syndrome (NS) remains controversial. Imbalance in peripheral blood regulatory and effector T cells (Teff) are linked to cell mediated immune response and may be associated with steroid response in NS. Peripheral blood CD4 + CD25 + FoxP3 + (Tregs), CD4 + IFN-γ + (Th1), and CD4 + IL-4 + (Th2) lymphocytes were analyzed in 22 steroid-sensitive NS (SSNS) patients in sustained remission, 21 steroid-resistant NS (SRNS) and 14 healthy controls. The absolute percentage values and ratio of Th1/Tregs, Th2/Tregs, and Th1/Th2 were compared between SSNS, SRNS and control subjects. The percentage of Tregs was lower in SRNS patients (P = 0.001) compared with that of SSNS and healthy control. The percentage of Th1 cells was higher in SRNS (P = 0.001) compared to that of SSNS patients; however, it was similar to healthy controls (P = 1.00). The percentage of Th2 cells in SRNS (P = 0.001) was higher as compared to SSNS and controls. The ratio of Th1/Treg cells in SRNS (P = 0.001) was higher as compared to SSNS patients and controls. The ratio of Th2/Treg was also higher in SRNS as compared to SSNS and controls. The ratio of Th1/Th2 cells in SSNS, SRNS, and healthy controls were similar. The cytokines secretion complemented the change in different T-cell subtypes in SSNS, SRNS and healthy controls. However, the IFN-γ secretion in healthy controles was low inspite of similar percentage of Th1 cells among SRNS cases. We conclude that greater ratio of Tregs compared to that Th1 and Th2 favor steroid sensitivity and reverse ratio results in to SRNS. The difference in ratio is related to pathogenesis or it can be used as marker to predict steroid responsiveness needs further evaluation.

1 January 2019 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YOYoontaek Oh
Yoontaek Oh
RNRyan Noga
Ryan Noga
VSVesselin Shanov
Vesselin Shanov
Hodon RyuHodon Ryu
Hodon Ryu
HCHarish Chandra
Harish Chandra
Soryong ChaeSoryong Chae
Soryong Chae

19 May 2015 in Nephrology
Verified
Journal Article
Closed access
PDF file
BYBRIJESH YADAV
BRIJESH YADAV
Narayan PrasadNarayan Prasad
Narayan Prasad
AJAkhilesh Jaiswal
Akhilesh Jaiswal
VAVinita Agrawal
Vinita Agrawal
MRMohit Rai
Mohit Rai
AKAnupama Kaul
Anupama Kaul

3 March 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Narayan PrasadNarayan Prasad
Narayan Prasad
BYBRIJESH YADAV
BRIJESH YADAV
MSMantabya Kumar Singh
Mantabya Kumar Singh
SGSonam Gautam
Sonam Gautam
DBDharmendra Bhadauria
Dharmendra Bhadauria
AKAnupama Kaul
Anupama Kaul
Vaccination-induced SARS-CoV-2 neutralizing antibodies are required for herd immunity. Vaccine availability and poor vaccine response in renal transplant recipients (RTRs) remain a concern. There is no report on the efficacy of Covaxin and Covishield vaccines in RTRs. We recruited 222 live donors RTRs and analyzed the serum titer of anti-SARS-CoV-2 spike protein antibody by chemiluminescent magnetic microparticle immunoassay. Patients were categorized into three groups: group1 with SARS-CoV-2 infection and no vaccination (n = 161); group 2 with only vaccination and no SARS-CoV-2 infection (n = 41); and group 3 with both vaccination and SARS-CoV-2 infection (n = 20). Overall seroconversion rate was 193/222 (86.9%) with a median titer 1095.20 AU/mL. The median IgG titer value in group 1 was 647.0 AU/mL; group 2 was 1409.0 AU/mL; and group 3 was 1831.30 AU/mL. Covaxin associated seroconversion was observed in 16/19 (84.21%), with a median titer of 1373.90 AU/mL compared to that of Covishield 32/42 (76.19%), whose median titer was 1831.10 AU/mL. The seroconversion rate due to SARS-CoV-2 infection was 145 (90.06%), it was lowest with the vaccination-only group (70.7%), and with both vaccination and SARS-CoV-2 infection group it was highest (95%). In RTRs, SARS-CoV-2 infection and both Covaxin and Covishield vaccination effectively induce a humoral immune response against the SARS-CoV-2 spike protein; however, seroconversion rate was lower and the antibody titer was higher with vaccine than infection.